This study reveals that WSX1 expression in tumors negatively regulates immune response in the tumor microenvironment via inducing apoptosis of T cells, and the receptor might be a new target in immune therapy to reverse tumor tolerance in the tumor microenvironment. The gene discussed is IL27RA; the disease is neoplasm.